PEPCK (phosphoenolpyruvate carboxykinase) a potential target for drugs that fight tuberculosis.
― In continuation of my update on tuberculosis and drug discovery ..... A new research conducted at Weill Cornell Medical College sheds light on a previously unrecognized aspect of fatty acid metabolism that could potentially lead to new targets for drug therapy. A team led by Dr. Sabine Ehrt, professor of microbiology and immunology at Weill Cornell Medical College, reported that Mtb relies primarily on gluconeogenic substrates for in vivo growth and persistence, and that phosphoenolpyruvate [...].
![[Blue prints]*](http://s2.bloggerscdn.com/media/t/14079133/14079133_s_1369116721.jpg)
